ストックスクリーナーアプリを入手
3.64
1.62%
-0.06
プレマーケット:
3.57
-0.07
-1.92%
Quantum Biopharma Ltd (QNTM) 最新ニュース
QNTM Should I Buy - Intellectia AI
Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Advances Proprietary Therapy for MS Treatment - The Globe and Mail
Quantum BioPharma Advances Lucid-MS Therapy for Multiple Sclerosis After Positive Phase 1 Trial - citybuzz -
Quantum BioPharma Ltd. Subordinate Voting Shares - The Canadian Securities Exchange (CSE)
Quantum BioPharma (QNTM) Builds Diversified Pipeline Across Neurological and Wellness Markets - Yahoo Finance
Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Builds Diversified Pipeline Across Neurological and Wellness Markets - TipRanks
symbol__ Stock Quote Price and Forecast - CNN
Quantum BioPharma (QNTM) Highlights Lucid-MS and unbuzzd™ Growth Opportunities on BioMedWire Podcast - NewMediaWire
Quantum BioPharma (QNTM) Highlights Lucid-MS and unbuzzd(TM) Growth Opportunities on BioMedWire Podcast - Yahoo Finance
Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Highlights Lucid-MS and unbuzzd(TM) Growth Opportunities on BioMedWire Podcast - TipRanks
Quantum BioPharma Hires Stocks.news for Investor Relations Services in $250,000 Deal - citybuzz -
Quantum BioPharma Advances Multiple Sclerosis Drug Candidate and Alcohol Metabolism Product - citybuzz -
Quantum BioPharma Hit by FDA Clinical Hold on Lead MS Drug as Director Resigns - TipRanks
Quantum BioPharma Highlights Lucid-MS and unbuzzd(TM) Growth Opportunities on BioMedWire Podcast - citybuzz -
[6-K] Quantum Biopharma Ltd. Current Report (Foreign Issuer) | QNTM SEC FilingForm 6-K - Stock Titan
Quantum BioPharma hires IR Agency for investor relations By Investing.com - Investing.com Australia
Quantum BioPharma Hires Stocks.news IR Agency to Boost Market Visibility - TipRanks
IBN Announces Latest Episode of The BioMedWire Podcast Featuring Anthony Durkacz, Executive Co-Chair of Quantum BioPharma Ltd. - The Manila Times
Quantum BioPharma Engages Stocks.news For Investor Relations, Marketing Services And Lead Generation Campaigns - The Manila Times
Quantum BioPharma Engages Stocks.news For Investor Relations, Marketing Services And Lead ... - Caledonian Record
Quantum BioPharma (QNTM) hires Stocks.news in US$250K investor relations push - Stock Titan
Quantum BioPharma Engages Stocks.news For Investor - GlobeNewswire
Quantum BioPharma Ltd. Provides Update on FDA Clinical Hold for Lucid-MS Drug Candidate - Quiver Quantitative
Quantum BioPharma Provides Corporate Update - Toronto Star
QNTM Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Quantum Biopharma Ltd. Q4 2025 Earnings: Wider Loss as Pre-Revenue Biotech Navigates Pipeline Progress - thelegaladvocate.com
Quantum BioPharma Advances MS Therapy, Diversifies Pipeline with Wellness Products - citybuzz -
Quantum BioPharma Momentum Surges Amid MS Resarch UpdateQuantum BioPharma (NASDAQ:QNTM) - Benzinga
Quantum Biopharma Ltd. (QNTM) Q4 2025 Earnings: Narrowing Losses Amidst No Revenue DisclosureEPS Surprise History - thelegaladvocate.com
Quantum Biopharma Ltd. (QNTM) Q4 2025 Earnings: Net Loss Deepens as Pre-Revenue Stock Sheds 23.7%Annual Earnings Summary - The League of Women Voters of Texas
QNTM Q4 2025 Earnings: Loss Per Share Reported, Shares Surge on Biotech ProgressTrough Earnings Signal - The Legal Advocate
Quantum Biopharma Ltd. (QNTM) Q4 2025 Earnings: Biotech Reports Wider Loss Amid Strategic Progress, Stock Jumps 18%Certified Trade Ideas - Newser
Quantum Biopharma Ltd. (QNTM) Q4 2025 Earnings: Pre-Revenue Biotech Reports Narrowed Loss, Shares RallyEstimate Accuracy - newsline.com
Quantum BioPharma Reaches Halfway Point in Patient Enrollment in Imaging Study With MGH - Moomoo
Quantum BioPharma (QNTM) Reports Midpoint Enrollment Milestone in MS Imaging Study - NewMediaWire
Quantum BioPharma Reaches Key Midpoint Milestone in Groundbreaking Imaging Study with Massachusetts General Hospital - Sahm
Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Reports Midpoint Enrollment Milestone in MS Imaging Study - TipRanks
Quantum BioPharma (QNTM) Achieves Key Enrollment Milestone in MS Study - GuruFocus
Quantum BioPharma Shares Climb as Multiple Sclerosis Imaging Study Advances (QNTM) - Yahoo Finance
Quantum BioPharma reaches midpoint in MGH MS imaging study - grafa.com
Quantum BioPharma stock surges on MS imaging study progress By Investing.com - Investing.com Australia
Quantum BioPharma stock surges on MS imaging study progress - Investing.com
Quantum BioPharma Hits Midpoint in MGH Imaging Study as Lucid-MS Advances Toward Phase 2 - TipRanks
Quantum BioPharma (NASDAQ: QNTM) advances MS imaging and Lucid-MS plans - Stock Titan
Quantum BioPharma Ltd. Achieves Halfway Point in Collaborative MS Imaging Study with Massachusetts General Hospital - Quiver Quantitative
Quantum BioPharma Reaches Key Midpoint Milestone in Groundbreaking Imaging Study with ... - Enidnews.com
1.27%
1.43%
大文字化:
|
ボリューム (24 時間):